Lantern Pharma Inc. Earnings Per Share, Basic and Diluted
Lantern Pharma Inc. (LTRN) reported Earnings Per Share, Basic and Diluted of -$1.13 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-10
- Lantern Pharma Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.32.
- Lantern Pharma Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.36.
- Lantern Pharma Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.21.
- Lantern Pharma Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.24.
- Lantern Pharma Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.13.
- Lantern Pharma Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.37.
- Lantern Pharma Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.23.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$0.68 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$0.89 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.13 10-K · filed 2022-03-10 |
| 2021-09-30 | -$0.36 10-Q · filed 2021-11-01 | -$0.57 derived: net income ÷ weighted average shares · filed 2021-11-01 | -$0.82 10-Q · filed 2021-11-01 | -$1.21 derived: net income ÷ weighted average shares · filed 2022-05-03 |
| 2021-06-30 | -$0.21 10-Q · filed 2021-07-29 | -$0.45 10-Q · filed 2021-07-29 | -$0.84 derived: net income ÷ weighted average shares · filed 2022-05-03 | -$1.11 derived: net income ÷ weighted average shares · filed 2022-05-03 |
| 2021-03-31 | -$0.24 10-Q · filed 2021-05-03 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-05-03 | -$0.94 derived: net income ÷ weighted average shares · filed 2022-05-03 | -$1.19 derived: net income ÷ weighted average shares · filed 2022-05-03 |
| 2020-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$0.74 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.37 10-K · filed 2022-03-10 |
| 2020-09-30 | -$0.27 10-Q · filed 2021-11-01 | -$0.49 derived: net income ÷ weighted average shares · filed 2021-11-01 | -$0.82 10-Q · filed 2021-11-01 | |
| 2020-06-30 | -$0.31 10-Q · filed 2021-07-29 | -$0.55 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | -$0.24 10-Q · filed 2021-05-03 | |||
| 2019-12-31 | -$1.23 10-K · filed 2021-03-10 | |||
| 2019-09-30 | -$0.34 10-Q · filed 2020-10-29 | -$0.89 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | -$0.32 10-Q · filed 2020-07-30 | -$0.55 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |